CCL2 and metabolic disease: Results of the study of hormonal and metabolic disorder connections in ACC patients have revealed higher tumor necrosis factor alpha (TNF-α), interleukin 6 (IL6) and monocyte chemoattractant protein 1 (MCP1) levels [128].